Showing results (401-410 of 9,400) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|January 12, 2017
QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac RepolarizationJ Keirns, A Desai, D Kowalski, et al.Clinical Pharmacology and Therapeutics|August 1, 1988
Renal tubular function in patients treated with high-dose cisplatinG Daugaard, U Abildgaard, N H Holstein-Rathlou, et al.Clinical Pharmacology and Therapeutics|November 7, 2021
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential ThrombocythemiaAlberto Tosetto, Bianca Rocca, Giovanna Petrucci, et al.Clinical Pharmacology and Therapeutics|March 1, 1986
Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndromeC M Stahl-Bayliss, C M Kalman, O L LaskinClinical Pharmacology and Therapeutics|December 16, 2021
The "Coming of Age" of Real-World Evidence in Drug Development and RegulationPeter K HonigClinical Pharmacology and Therapeutics|February 17, 2019
Bispecific Antibodies in the Treatment of Hematologic MalignanciesJohannes Duell, Philip E Lammers, Ivana Djuretic, et al.Clinical Pharmacology and Therapeutics|August 23, 2019
DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy VolunteersHendrika W Grievink, Jules A A C Heuberger, Fen Huang, et al.Clinical Pharmacology and Therapeutics|September 1, 1988
Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placeboD J Greenblatt, J S Harmatz, C Dorsey, et al.Clinical Pharmacology and Therapeutics|August 4, 2019
Evolving Vision of Regulatory Science in the Global Medical CommunityTatsuya Kondo, Yoshikazu Hayashi, Junko Sato, et al.Clinical Pharmacology and Therapeutics|September 1, 1987
Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosisA Koshy, A Hadengue, S S Lee, et al.Pageof 940